Related Experiment Video
Updated: Nov 25, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.0K
Telehealth in type 1 diabetes
Tejaswi Kompala1, Aaron B Neinstein1,2
1Department of Medicine.
Current Opinion in Endocrinology, Diabetes, and Obesity
|December 17, 2020
Summary
Telehealth is effective for type 1 diabetes (T1D) care, matching in-person visits for glycemic control. This technology improves access, engagement, and satisfaction for T1D management, with future potential for advanced decision support.
Area of Science:
- Endocrinology
- Digital Health
- Diabetes Management
Background:
- The coronavirus pandemic accelerated telehealth adoption in type 1 diabetes (T1D) care.
- Telehealth is poised to remain a primary care delivery method for T1D.
Purpose of the Study:
- To review current evidence on telehealth applications in T1D care.
- To explore the evolving landscape of digital health for T1D management.
Main Methods:
- Systematic review of recent literature on telehealth in T1D.
- Analysis of studies evaluating glycemic control, patient engagement, and satisfaction.
Main Results:
- Telehealth demonstrates equivalence to in-person care for glycemic control in T1D.
- Telehealth enhances access, convenience, and patient satisfaction, particularly for adolescents.
- Platforms are effective for managing microvascular complications and diabetes-related mental health.
- Emerging digital services and machine learning offer advanced decision support for daily T1D management.
Conclusions:
- A growing body of evidence supports telehealth for T1D.
- Scaling telehealth can broaden access to high-quality diabetes care.
- Policy and system changes are crucial for data interoperability, reimbursement, and sustained telehealth growth in T1D.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
726
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
726
01:22Diabetes Mellitus: Overview and Type I Subtype
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.4K
01:22Diabetes Mellitus: Type 2 and Gestational
3.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.6K
01:16Insulin: Dosing Regimen and Adverse Effects
465
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
465
01:36Carbohydrate Metabolism
13.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.1K